Stock Screener App

Frei -

Installieren

0.00

100.00% -2.38

Cassava Sciences Inc (SAVA)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt SAVA? Forum Prognose Aktiensplit Dividendenhistorie

Cassava Sciences Inc Aktie (SAVA) Neueste Nachrichten

Cassava Sciences says DOJ has closed probe into allegations around its Alzheimer’s program - MSN

Filana Therapeutics (FLNA) details 2026 meeting and equity plan vote - Stock Titan

Cassava Sciences (FLNA) Financials 2026Income Statement and Balance Sheet $FLNA - MarketBeat

Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 10, 2025 in Cassava Sciences, Inc. LawsuitSAVA - ACCESS Newswire

Cassava Sciences (FLNA) Institutional Ownership 2026 $FLNA - MarketBeat

Cassava Sciences Inc Share PriceShare CFDs - FOREX.com

Cassava Sciences (NASDAQ:SAVA) Stock Price Down 0.6%Should You Sell? - MarketBeat

SAVA SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Cassava Sciences, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

FLNA Stock Price, News & Analysis - Stock Titan

Filana Therapeutics Announces Publication in Epilepsia of Preclinical Simufilam Data - GlobeNewswire

Death Cross: What are the future prospects of Cassava Sciences Inc Equity WarrantPortfolio Gains Summary & Verified Chart Pattern Trade Signals - baoquankhu1.vn

FLNA|Cassava Sciences Ord Shs|Price:1.590|Chg%:-0.02 - TradingKey

FLNA|Cassava Sciences Ord Shs|Price:1.440|Chg%:-0.12 - TradingKey

If You Invested $1,000 in Cassava Sciences (SAVA) - Stock Titan

Trend Report: What is the dividend yield of Cassava Sciences Inc Equity Warrant2026 Geopolitical Influence & Entry and Exit Point Strategies - baoquankhu1.vn

Aug Chart Watch: Is Cassava Sciences Inc Equity Warrant trading at a discountWeekly Market Outlook & High Accuracy Swing Trade Signals - baoquankhu1.vn

Market Leaders: Can Cassava Sciences Inc Equity Warrant maintain its current growth rate2026 Levels & Low Risk Investment Opportunities - baoquankhu1.vn

Aug Update: Is Cassava Sciences Inc Equity Warrant subject to activist investor interestWatch List & Consistent Return Investment Signals - baoquankhu1.vn

RSI Check: What is the dividend yield of Cassava Sciences IncPortfolio Performance Report & High Conviction Buy Zone Alerts - baoquankhu1.vn

SEC Moves To Set Up $40M Investor Fund In Cassava Case - Law360

Cassava Sciences Stock Rises 1.8% - National Today

Cassava Sciences (NASDAQ:SAVA) Stock Price Up 1.8%Here's What Happened - MarketBeat

RSI Check: Is Cassava Sciences Inc backed by strong institutional buying2026 PreEarnings & Fast Entry Momentum Alerts - baoquankhu1.vn

Dow Update: What is the dividend yield of Cassava Sciences Inc Equity WarrantInsider Selling & Proven Capital Preservation Tips - baoquankhu1.vn

Cassava Sciences, Inc. (FLNA) - Minichart

Energy Moves: What is Cassava Sciences Inc Equity Warrants book value per share - baoquankhu1.vn

SAVA PE Ratio & Valuation, Is SAVA Overvalued - Intellectia AI

ETF Watch: What are the future prospects of Cassava Sciences Inc Equity WarrantPortfolio Risk Report & Free Community Consensus Stock Picks - baoquankhu1.vn

Shareholders that lost money on Cassava Sciences, Inc.(SAVA) Urg - GuruFocus

Cassava Sciences, Inc. Common Stock (FLNA) Competitors - Meyka

FOMO Trade: Does Cassava Sciences Inc Equity Warrant offer margin of safety2026 Key Highlights & Expert Approved Momentum Ideas - baoquankhu1.vn

Trading Recap: Is Cassava Sciences Inc Equity Warrant subject to activist investor interest2026 Sentiment & Daily Stock Trend Watchlist - baoquankhu1.vn

Block Trades: Does Cassava Sciences Inc Equity Warrant have pricing powerMarket Sentiment Summary & Long-Term Growth Stock Strategies - baoquankhu1.vn

Cassava Sciences, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before February 10, 2025 to Discuss Your RightsSAVA - marketscreener.com

Cassava Sciences, Inc. Class Action: The Gross Law Firm Reminds Cassava Sciences, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 10, 2025SAVA - marketscreener.com

Filana Therapeutics, Inc.: Target Price Consensus and Analysts Recommendations | PX91 | US14817C1071 - marketscreener.com

Shareholders of Cassava Sciences, Inc. Should Contact The Gross Law Firm Before February 10, 2025 to Discuss Your RightsSAVA - marketscreener.com

Filana Therapeutics Inc (FLNA-Q) Profile - The Globe and Mail

Filana Therapeutics Inc (FLNA-Q) Stock Price and News - The Globe and Mail

Cassava Sciences, Inc. Class Action: Levi & Korsinsky Reminds Cassava Sciences, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 10, 2025SAVA - marketscreener.com

Filana Therapeutics, Inc.: Target Price Consensus and Analysts Recommendations | SAVA * | US14817C1071 - marketscreener.com

FLNA Stock News Today | Earnings, Events & Price Alerts - Intellectia AI

Cassava Sciences Posts Earnings, Beats Estimates - National Today

Cassava Sciences (NASDAQ:SAVA) Posts Earnings Results, Beats Estimates By $0.04 EPS - MarketBeat

Filana Therapeutics (NASDAQ: SAVA) pivots to TSC epilepsy amid FDA clinical hold - Stock Titan

Total equity of Cassava Sciences, Inc. – BMV:FLNA - TradingView

Average basic shares outstanding of Cassava Sciences, Inc. – BMV:FLNA - TradingView

Cassava Sciences, Inc. Cash Flow – BMV:FLNA - TradingView

Price to book ratio of Cassava Sciences, Inc. – BMV:FLNA - TradingView

Free cash flow per share of Cassava Sciences, Inc. – BMV:FLNA - TradingView

Long term debt to total equity ratio of Cassava Sciences, Inc. – BMV:FLNA - TradingView

Cassava Sciences, Inc. Earnings and Revenue – BMV:FLNA - TradingView

Cassava Sciences, Inc. Balance Sheet – BMV:FLNA - TradingView

ETFs Investing in Cassava Sciences, Inc. Stocks - TradingView

FLNA Forecast — Price Target — Prediction for 2027 - TradingView

Filana Therapeutics (NASDAQ: FLNA) pivots to TSC epilepsy amid $91M loss - Stock Titan

Biotech that ditched Alzheimer's drug pivots to epilepsy, slashes R&D 62% - Stock Titan

Filana Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results - Bitget

Rate Cut: Can Cassava Sciences Inc beat the S P 500Global Markets & Growth Focused Entry Point Reports - baoquankhu1.vn

FLNA Stock Price and Chart — NASDAQ:FLNA - TradingView

ROIV

$28.53

3.67%

RPRX

$50.09

1.21%

BNTX

$103.45

1.85%

INSM

$136.33

0.96%

RVMD

$144.12

2.54%

ONC

$295.27

1.54%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters